Market Cap: $180.51M
PI
Precision BioSciences, Inc.
DTIL
NASDAQ (NASDAQ Global Select)USD
Market Cap: $180.51M
Precision BioSciences Enhances Leadership Team to Propel Gene Editing Advancements Precision BioSciences, Inc., a clinical-stage gene editing company, is poised for significant growth with the recent…
Precision BioSciences Advances Gene Editing Innovations Through Strategic Engagements Precision BioSciences, Inc., a leading clinical-stage gene editing company based in Durham, North Carolina, is set…
Precision BioSciences: Leading the Charge in Gene Editing Innovation Precision BioSciences, Inc., a clinical-stage gene editing company based in Durham, North Carolina, is at the forefront of advancin…
Precision BioSciences Advances Gene Editing Therapy for Chronic Hepatitis B Precision BioSciences, Inc. is taking significant strides in the fight against chronic hepatitis B with the clinical develop…
Precision BioSciences Advances in Gene Editing for Chronic Hepatitis B Treatment Precision BioSciences, Inc. achieves a significant milestone with the clearance of its first clinical trial application…
Precision BioSciences Moves Forward with PBGENE-HBV Clinical Trials Precision BioSciences, Inc. makes significant strides in the fight against chronic hepatitis B with the recent clearance of its firs…
Precision BioSciences Advances Gene Editing with ARCUS Platform Precision BioSciences, Inc., a clinical-stage gene editing company, prepares to unveil its third-quarter financial results and provide a…